[Experience with three minipills preparations with low dose progestagens for oral contraception].
Richter
R H
RH
Anhst-horridge
A
A
Riemann-hunziker
R
R
Roth
F
F
Sprenger
S
S
Turpeinen
K
K
D001519:Behavior; D002490:Central Nervous System; D002715:Chlormadinone Acetate; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D004064:Digestive System; D004194:Disease; D005193:Family Planning Services; D006470:Hemorrhage; D016912:Levonorgestrel; D007989:Libido; D019290:Megestrol Acetate; D008796:Metrorrhagia; D009325:Nausea; D012106:Research; D012725:Sexual Behavior; D012816:Signs and Symptoms
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D002715:Chlormadinone Acetate; D016912:Levonorgestrel; D019290:Megestrol Acetate
Behavior; Bleeding; Central Nervous System Effects; Chlormadinone Acetate; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Decreased Libido; Diseases; Family Planning; Gastrointestinal Effects; Levonorgestrel; Megestrol Acetate; Metrorrhagia; Nausea; Oral Contraceptives; Oral Contraceptives, Low-dose; Research Methodology; Sex Behavior; Signs And Symptoms